Publication | Closed Access

Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma

NanomedicineDrug TargetingEngineeringPolymer-drug ConjugateMedicineTherapeutic NanomaterialsEnhanced DeliveryTumor TargetingNano-drug DeliveryBiomedical EngineeringTargeted TherapyPharmacologyHepatocellular Carcinoma